Cargando…
Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017
At the annual ASCO meeting clinically relevant data concerning the management of advanced head and neck cancer that will influence clinical practice in the future were presented. Chemoradiation with high-dose cisplatin remains the mainstay of treatment for patients with locally advanced squamous cel...
Autores principales: | Magnes, Teresa, Egle, Alexander, Greil, Richard, Melchardt, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725515/ https://www.ncbi.nlm.nih.gov/pubmed/29250200 http://dx.doi.org/10.1007/s12254-017-0358-9 |
Ejemplares similares
-
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
por: Magnes, Teresa, et al.
Publicado: (2021) -
ASCO-update: gastrointestinal tumors
por: Weiss, Lukas, et al.
Publicado: (2017) -
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy
por: Magnes, Teresa, et al.
Publicado: (2017) -
Head and Neck Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2022) -
ASCO update on lymphoma
por: Fridrik, Michael A.
Publicado: (2017)